Quick Preview

✔️ Ischemic Optic Neuropathy – Optic Neuritis (OD)
54F
Sudden visual decline (“curtain” over eye)
Treated with steroids initially — no improvement
Improved in VA, contrast sensitivity, and field after 18 coMra sessions


Ischemic Optic Neuropathy — Optic Neuritis (Right Eye)

(Click to Expand)

Quick Facts

  • Patient: 54-year-old female
  • Condition: Ischemic Optic Neuropathy – Optic neuritis in right eye (OD)
  • Context: “Curtain” over vision; MRI/CAT negative; no inflammatory/traumatic cause; stress suspected. Prior steroids failed.
  • Protocol: Duration from onset to start not specified. 18 treatments over ~2 months. Eye Protocol (point 2). Weekly acupuncture.
  • Outcome Highlights: Acuity ~20% better (to 20/40); field defects 14 → 9 at series end; → 5 one month later.

🔗 View Protocol Used

📂 Expand Full Case Details

Case Details

Medical History: None reported
Medications at Start: Prednisone (discontinued)

Practitioner Notes:

  • Continued improvement after the series ended
  • Color fields expanded; fewer blind spots
  • Patient noticed clearer vision near/far, better peripheral awareness

Patient Comment:
“It’s a lot less and so a lot less disturbing.”

Follow-up: Lost to follow up

Related science:

  • Coordinated low-intensity therapies — combining gentle electrical stimulation, millimeter-wave fields, and low-intensity laser, synchronized to patient rhythms — improved acuity and fields in partial optic-nerve atrophy across etiologies (n=443 eyes; vascular subgroup n=88, Baranov 2016), paralleling this case’s VA/field gains.

  • Magnet-based regimens enhanced conduction and perfusion in glaucoma (n=634 eyes, Kamenskikh 2015). In addition, transcranial magneto-laser therapy elevated neurotrophic factors and improved afferent conduction (n=217 eyes; 126 treated vs 91 controls, Egorov 2016), supporting mechanisms of optic-nerve recovery.

See more → Research Gallery


✅ Next Steps for Clinicians

📂 Expand For Details

📅 Book a Call

Explore how coMra could fit into your care model Schedule a Conversation →

📄 Download Clinical Brief

Access protocols and objective outcomes
Get the Brief

💬 Ask a Clinical Question

Get direct answers from our clinical team
Submit Your Question →📨

👉 Return to Eye Main Page